Vouched has announced a new integration that connects its healthcare-focused identity verification system with Epic's software toolbox.

DAVENPORT, Iowa - March 17, 2026 - PRESSADVANTAGE - Amana Care Clinic has announced enhanced walk-in medical services ...

Healthcare organizations appear to be destroying the transcripts after a certain time, as protection against possible ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed inno ...

Objective: The aim was to study the epidemiological aspects of febrile seizures and to identify etiologies in children from 1 ...

Lead program VMT-α-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as ...

DATATRAK Powered by Fountayn and TAILRD Heart collaborate to bring real-world data (RWD) and artificial intelligence (AI) solutions to cardiovascular care and clinical research AUSTIN, TX / ACCESS New ...

Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ALS.

After severe abdominal pain sent her to the ER, a Canadian woman faced a 15-hour wait, as physicians warn of worsening ...

Exclusive: Guardian investigation finds data from flagship medical research leaked dozens of times ...

Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the Arexvy vaccine.